Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,746,143
-$602,563 QoQ
Shares Held
197,099
+3.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#617
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $104,508,931 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,524 | $33,013,114 | |
| 2 | JNJ |
Johnson & Johnson
|
85,199 | $21,637,990 | |
| 3 | ABBV |
AbbVie Inc.
|
61,181 | $15,395,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,774 | $12,049,959 | |
| 5 | AMGN |
Amgen Inc
|
18,865 | $6,831,393 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,580 | $5,505,897 | |
| 7 | PFE |
Pfizer Inc
This page
|
197,099 | $4,746,143 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
72,834 | $4,196,695 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,746,143 | 197,099 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,348,706 | 190,481 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,749,874 | 190,758 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,075,182 | 199,183 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,781,267 | 197,247 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,967,121 | 196,019 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,129,522 | 193,348 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $5,670,793 | 195,950 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,364,045 | 191,710 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,005,127 | 216,401 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,029,863 | 209,443 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,892,659 | 207,798 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $6,865,982 | 187,186 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,387,362 | 156,553 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $7,560,666 | 147,554 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $5,955,298 | 136,090 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,955,995 | 113,599 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,567,397 | 107,541 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $5,670,040 | 96,021 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,036,118 | 70,591 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,245,904 | 57,352 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,077,862 | 57,352 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,111,127 | 57,352 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,744,716 | 47,540 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,061,737 | 32,469 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,068,991 | 32,751 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||